SCHEMBL21167439

SCHEMBL21167439

COCCn1cc(-c2cnc(N=N)c(NCc3cc(N)c(C=N)s3)n2)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 2/20 0.37
FEN1 P39748 1/20 0.35
FGFR1 P11362 4/20 0.34
FGFR2 P21802 4/20 0.34
FGFR4 P22455 4/20 0.34
FGFR3 P22607 4/20 0.34
KDR P35968 4/20 0.34
IKBKE Q14164 5/20 0.33
TBK1 Q9UHD2 5/20 0.33
CSF1R P07333 1/20 0.33
ALOX5AP P20292 2/20 0.32
BRD4 O60885 1/20 0.32
TYRO3 Q06418 1/20 0.32
LIPC P11150 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CG P48736 1/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
JAK3 P52333 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21167440 0.90 CSF1R (0.42) SYKFEN1FGFR1FGFR2FGFR4
SCHEMBL22475903 0.87 SYK (0.37) SYKFEN1FGFR1FGFR2FGFR4
SCHEMBL21167411 0.79 CSF1R (0.41) SYKFEN1FGFR1FGFR2FGFR4
SCHEMBL22475803 0.77 SYK (0.35) SYKFEN1FGFR1FGFR2FGFR4
SCHEMBL21167672 0.77 CSF1R (0.56) FGFR1FGFR2FGFR3KDRCSF1R
SCHEMBL21167475 0.75 MET (0.45) SYKFEN1FGFR1FGFR2FGFR4
SCHEMBL22475817 0.75 CSF1R (0.45) SYKFGFR1FGFR2FGFR4FGFR3
SCHEMBL23127952 0.75 MET (0.48)
SCHEMBL24591027 0.75 CSF1R (0.39) FGFR1FGFR2FGFR3CSF1RALOX5AP
SCHEMBL22475775 0.73 MET (0.34) CSF1RALOX5APTYRO3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795573-B1 CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LTD (CN) 2022-07-06 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed